Treatment of colitis in Behcet's disease with thalidomide

被引:0
|
作者
Postema, PTE [1 ]
denHaan, P [1 ]
vanHagen, PM [1 ]
vanBlankenstein, M [1 ]
机构
[1] UNIV ROTTERDAM HOSP, DEPT INTERNAL MED, NL-3015 GD ROTTERDAM, NETHERLANDS
关键词
Behcet's disease; colitis; thalidomide; chronic myeloid leukaemia;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
A 40-year-old Turkish man on busulphan treatment for chronic myeloid leukaemia was hospitalized with steroid resistant (up to 100 mg prednisolone/24 h for over 4 weeks) colitis. On the basis of concomitant orogenital ulceration and unusual, deep punched out ulcers in the colon and smaller ulcers in the terminal ileum, Behcet's disease of the bower, manifesting as ileocolitis, was diagnosed. Leukaemic infiltration, Crohn's colitis, neutropenic colitis and infectious colitis were excluded by histology and cultures. Treatment with colchicine 2 mg/day improved the orogenital ulcers but with only minor improvement of the colitis. Thalidomide treatment (400 mg/day), however, dramatically improved the colitis within 7 days: fever and diarrhoea disappearing. Colonoscopy after 4 weeks of treatment revealed previously giant ulcers practically healed.
引用
收藏
页码:929 / 931
页数:3
相关论文
共 50 条
  • [31] Problem of differential diagnosis between Crohn's disease and colitis in Behcet's disease: a case report
    Portuesi, M. G.
    Lancia, M.
    Ciuffreda, L.
    REUMATISMO, 2010, 62 (02) : 127 - 130
  • [32] Combination therapy of infliximab and thalidomide for refractory entero-Behcet's disease: a case report
    Yue Li
    Zelong Han
    Xianfei Wang
    Zhihui Mo
    Wei Zhang
    Aimin Li
    Side Liu
    BMC Gastroenterology, 13
  • [33] Combination therapy of infliximab and thalidomide for refractory entero-Behcet's disease: a case report
    Li, Yue
    Han, Zelong
    Wang, Xianfei
    Mo, Zhihui
    Zhang, Wei
    Li, Aimin
    Liu, Side
    BMC GASTROENTEROLOGY, 2013, 13
  • [34] Treatment of pediatric refractory Crohn’s disease with thalidomide
    Ying-Kit Leung
    World Journal of Gastroenterology, 2011, 17 (10) : 1286 - 1291
  • [35] Treatment of pediatric refractory Crohn's disease with thalidomide
    Zheng, Cui-Fang
    Xu, Jia-Hua
    Huang, Ying
    Leung, Ying-Kit
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (10) : 1286 - 1291
  • [36] The potential of genetically guided treatment in Behcet's disease
    Gheita, Tamer A.
    Gheita, Heba A.
    Kenawy, Sanaa A.
    PHARMACOGENOMICS, 2016, 17 (10) : 1165 - 1174
  • [37] Laryngeal involvement in Behcet’s disease—a challenge for treatment
    Menachem Gross
    Eldad Ben-Chetrit
    Clinical Rheumatology, 2013, 32 : 75 - 77
  • [38] Behcet's disease - Infliximab in the treatment of mucocutaneous manifestations
    Lestre, Sara
    Trindade, Felicidade
    Martins, Andrea
    Baptista, Juliana
    Feio, Ana Barata
    Paiva Lopes, Maria Joao
    ACTA REUMATOLOGICA PORTUGUESA, 2009, 34 (04): : 633 - 640
  • [39] Endovascular treatment in Behcet's disease: an integrative review
    Dumont, Ligia Sant'Ana
    de Oliveira Cunha, Renan Rodrigues
    Alves Cardoso, Thais Carolina
    Fleury, Lygia Gomes
    Santos Nunes, Augusto Wagner
    Franca Oliveira, Pablo Ricardo
    Cardoso, Higor Chagas
    JORNAL VASCULAR BRASILEIRO, 2022, 21
  • [40] Efficacy of etanercept in the treatment of a patient with Behcet's disease
    Curigliano, Valentina
    Giovinale, Maria
    Fonnesu, Claudia
    Cerquaglia, Claudia
    Verrecchia, Elena
    Turco, Simona
    Manganelli, Chiara
    Manna, Raffaele
    CLINICAL RHEUMATOLOGY, 2008, 27 (07) : 933 - 936